Results 91 to 100 of about 6,482 (100)

Th17 cells in neuromyelitis optica spectrum disorder: a review

International Journal of Neuroscience, 2016
Junhui Xia
exaly  

A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia

Multiple Sclerosis Journal, 2019
Shanthi Viswanathan
exaly  

<p>Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer</p>

Clinical Interventions in Aging, 2019
Junliang Yuan, Wei Qin, Wenli Hu
exaly  

The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses

Multiple Sclerosis Journal, 2014
Su-Hyun Kim, Jae-Won Hyun, Boram Park
exaly  

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2017
De-Cai Tian, Chun-Sheng Yang, Fu-Dong Shi   +2 more
exaly  

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2013
Su-Hyun Kim, So-Young Huh, Sun Ju Lee
exaly  

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

New England Journal of Medicine, 2019
Takashi Yamamura, Ingo Kleiter, Kazuo Fujihara   +2 more
exaly  

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Lancet, The, 2019
Bruce A C Cree, Jeffrey Bennett, Ho Jin Kim   +2 more
exaly  

Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal, 2016
Takashi Ohashi, Ichiro Nakashima, Tatsuro Misu   +2 more
exaly  

Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies

Multiple Sclerosis Journal, 2018
Maria Sepulveda, Núria Sola-Valls, D Escudero   +2 more
exaly